GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » EV-to-EBITDA

Pulike Biological Engineering (SHSE:603566) EV-to-EBITDA : 48.36 (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pulike Biological Engineering's enterprise value is ¥7,318 Mil. Pulike Biological Engineering's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥151 Mil. Therefore, Pulike Biological Engineering's EV-to-EBITDA for today is 48.36.

The historical rank and industry rank for Pulike Biological Engineering's EV-to-EBITDA or its related term are showing as below:

SHSE:603566' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.77   Med: 41.5   Max: 118.26
Current: 48.36

During the past 13 years, the highest EV-to-EBITDA of Pulike Biological Engineering was 118.26. The lowest was 7.77. And the median was 41.50.

SHSE:603566's EV-to-EBITDA is ranked worse than
85.14% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs SHSE:603566: 48.36

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Pulike Biological Engineering's stock price is ¥23.00. Pulike Biological Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.390. Therefore, Pulike Biological Engineering's PE Ratio for today is 58.97.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Pulike Biological Engineering EV-to-EBITDA Historical Data

The historical data trend for Pulike Biological Engineering's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering EV-to-EBITDA Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.55 19.76 20.65 34.32 25.22

Pulike Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.99 34.17 28.23 25.22 35.67

Competitive Comparison of Pulike Biological Engineering's EV-to-EBITDA

For the Biotechnology subindustry, Pulike Biological Engineering's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's EV-to-EBITDA falls into.



Pulike Biological Engineering EV-to-EBITDA Calculation

Pulike Biological Engineering's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=7318.327/151.32
=48.36

Pulike Biological Engineering's current Enterprise Value is ¥7,318 Mil.
Pulike Biological Engineering's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥151 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulike Biological Engineering  (SHSE:603566) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pulike Biological Engineering's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=23.00/0.390
=58.97

Pulike Biological Engineering's share price for today is ¥23.00.
Pulike Biological Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.390.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Pulike Biological Engineering EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines